Altretamine Articles
MGI buys Hexalen from MedImmune
15 November 2000
US Biosciences halts lodenosine HIV trial after death of patient
15 October 1999
Medeva Bladder Cancer Drug Filed In USA
15 January 1998
Beaufour Ipsen And QLT In European Licensing Deal
6 January 1997
USB, Alza Extend Product Collaboration
3 June 1996
US Bioscience Signs Euro Marketing Deal
17 July 1995
Eli Lilly Canada; Hexalen and Ethyol
8 May 1995
US BIO'S HEXALEN IN OVARIAN CANCER
11 April 1994
BREAST CANCER US RESEARCH UPDATE
26 April 1993
APPROVAL SETBACK FOR US BIOSCIENCE
10 February 1992
Showing 1-10 of 10 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
